News

News

MicroPort® Hosts Teleconference of TARGET PREMIER Study on Next Generation Rapamycin Target Eluting Stent -

Researchers met remotely in a recent teleconference for the TARGET PRE...

Endovastec™ Debuts at Pan-American Congress on Vascular and Endovascular Surgery -

Shanghai MicroPort Endovascular MedTech Co., Ltd. (Endovastec™) recent...

MicroPort® CRM Announces Completion of Patient Recruitment for the Primary Objectives of the Apollo Study on Invicta Defibrillation Lead -

MicroPort CRM today announced the completion of patient recruitment in...

MicroPort® Toumai® Laparoscopic Surgery Robot's Clinical Trials -

The multi-center clinical trial, ‘Robotic-assisted thoracic, abdominal...

Clinical Trial Enrollment Completed for the First Endovastec™ Venous Stent -

Shanghai MicroPort Endovascular MedTech(Group)Co., Ltd. (Endovastec™) ...

MicroPort® Shared Latest Research Results at China Heart Congress (CHC) and 6th China Vascular Congress (CVC) -

Recently, Shanghai MicroPort Medical (Group) Co., Ltd. (MicroPort®) pr...

MicroPort® Orthopedics Receives FDA 510(k) Approval for Two Hip Products -

The Dynasty® Dual Mobility Acetabular Liners and the E-Class® Vitamin ...

Construction Begins on 280,000-Square-Meter MicroPort® MegaFactory and Global Medical Experience Center -

Recently, MicroPort Scientific Corporation (00853.HK, “MicroPort®") si...

MicroPort® Purchases Property for Miracle Point Innovation Center for New Materials and Medical Devices -

MicroPort Scientific Corporation (00853.HK, “MicroPort®”) recently ann...

C Lowry Barnes, M.D. Joins MicroPort® Orthopedics as Medical Director -

MicroPort® Orthopedics announced that C. Lowry Barnes, MD, Chair of Or...

MicroPort® Acquires German ECLS Company Hemovent® GmbH and Invests in Expansion of German Operations -

MicroPort Scientific Corporation (hereinafter referred to as “MicroPor...

Chinese-developed Honghu Orthopedic Surgical Robot Completes First 5G Remote Joint Replacement Surgery -

Recently, the Honghu Orthopedic Surgical Robot (Honghu), developed by ...

VitaFlow Liberty™ Completes Implantations across 15 Hospitals on the First Day after Market Launch -

MicroPort CardioFlow Medtech Corporation (CardioFlow Medtech) announce...

MicroPort® Completes Subject Enrollment for Firesorb® FUTURE-III Pivotal Trial -

Shanghai MicroPort Medical (Group) Co., Ltd. (MicroPort®), has complet...

MicroPort® Announces Strategic Investment with Kerui Pharma -

MicroPort Scientific Corporation (MicroPort®) announced that its subsi...

MicroPort® NeuroTech NUMEN Coil Embolization System Approved for Market in Korea -

The NUMEN® Coil Embolization System (NUMEN®) and NUMEN FR® Detachment ...